ARWR
Arrowhead Pharmaceuticals Inc
65.90$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -21.3% | -2.9% | -20.8% | -28.9% | +37.3% | +2,285.0% | +686.0% | +143.7% | +18.9% | -13.5% | -42.2% | -55.4% | +60.4% | +28.6% | +4.0% | +125.9% | +389.7% | -27.7% | -3.1% | -18.8% | +7.3% | +213.5% | +49.4% | +35.9% | -2.6% | +10.6% | +48.9% | +21.5% | |
| – | -13.5% | -10.7% | -39.0% | +185.2% | -30.0% | +4,612.9% | +527.3% | +140.2% | +26.1% | -12.1% | -58.3% | -76.5% | +227.4% | +21.3% | -33.4% | +339.2% | +436.7% | -33.5% | -12.0% | -25.0% | +16.0% | +236.7% | +21.5% | +19.3% | +5.4% | +3.5% | +65.8% | +36.7% | |
| – | -12.6% | -87.8% | +1,474.2% | -86.1% | +6,723.2% | +7,229.5% | +531.1% | +162.7% | +24.7% | -13.9% | -58.2% | -80.0% | +238.9% | +9.6% | -55.0% | +466.0% | +593.2% | -38.7% | +5.1% | -70.9% | +21.3% | +636.1% | -35.3% | +28.5% | -41.4% | +2.7% | -7.4% | +120.6% | |
| – | -12.6% | -87.8% | +1,474.2% | -86.1% | +6,723.2% | +7,229.5% | +567.1% | +149.4% | +24.3% | -13.9% | -58.2% | -80.0% | +238.9% | +18.9% | -57.2% | +707.9% | +447.8% | -35.9% | -13.6% | -23.1% | +16.7% | +238.0% | +22.0% | +16.6% | +2.3% | +7.2% | +68.7% | +35.0% | |
| – | -69.5% | +255.9% | -88.7% | -50.0% | – | – | – | -35.5% | +121.9% | +272.0% | -68.6% | +70.0% | +532.0% | +72.8% | +53.3% | -96.6% | -10.4% | +0.0% | +0.0% | -9.6% | +382.9% | +102.0% | +27.9% | +1,112.6% | -86.3% | -100.0% | – | – | |
| – | +3.5% | -36.4% | -14.5% | -51.5% | +119.5% | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | -32.8% | +46.2% | +161.7% | +28.1% | +2.6% | -595.5% | – | – | – | |
| – | – | – | – | – | – | -93.8% | +44,000.0% | +22.2% | +17.9% | +13.2% | -13.5% | -57.7% | -73.2% | -82.0% | +19,146.2% | -28.2% | +10.2% | +16.9% | +239.9% | +0.8% | -10.2% | +66.6% | +33.0% | +57.6% | +126.6% | +204.2% | – | – | |
| – | – | – | – | – | – | – | – | +341.6% | -45.3% | +205.1% | -6.4% | -14.1% | -13.4% | -15.4% | +176.4% | -32.3% | -68.7% | +2,349.4% | -10.7% | -7.7% | -8.3% | -9.1% | -10.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +208.4% | +2.4% | -12.4% | -6.4% | -14.1% | -13.4% | -15.4% | +176.4% | -32.3% | -68.7% | +2,349.4% | -10.7% | -7.7% | -8.3% | -9.1% | -10.0% | -11.1% | -12.4% | -14.2% | -16.6% | -19.9% | |
| – | +1.1% | -60.2% | +10.7% | +13.1% | +19.5% | -94.0% | +617.1% | +48.5% | +185.2% | +16.3% | +45.8% | -42.6% | +50.3% | -22.3% | +132.2% | +50.2% | +45.2% | +34.5% | +46.4% | -30.2% | -29.3% | +546.4% | -42.6% | +396.2% | -9.2% | +74.9% | +98.3% | -7.0% | |
| – | -0.6% | -61.2% | +11.6% | +14.1% | +20.4% | -93.9% | +617.1% | +48.5% | +185.2% | -0.8% | +28.7% | -37.1% | +82.4% | -39.6% | +106.4% | +63.8% | +35.8% | +34.2% | +61.3% | -27.1% | -33.9% | +685.0% | -58.1% | +260.2% | -5.2% | -24.1% | -2.2% | +89.5% | |
| – | +0.1% | -49.1% | +0.4% | +0.4% | +15.2% | – | – | – | – | – | -22.1% | -10.4% | -31.2% | +89.0% | -77.3% | +455.4% | -77.9% | -17.6% | -10.7% | +7.3% | +7.3% | +5,098.2% | -90.6% | +105.5% | +23.4% | +280.5% | -40.0% | +645.6% | |
| – | -0.7% | -88.0% | -5.0% | +12.0% | +43.6% | -64.1% | +483.4% | -12.7% | +79.4% | +59.4% | -0.5% | -24.5% | -32.7% | -15.4% | +52.2% | +36.6% | +115.0% | +95.1% | +143.1% | -66.7% | -31.2% | +172.6% | -10.7% | +38.5% | -69.7% | +1,150.6% | -68.2% | +55.2% | |
| – | – | – | – | -15.4% | -15.2% | – | – | – | – | – | – | -31.1% | – | – | +38.3% | +32.4% | -31.8% | -28.6% | +368.3% | -8.2% | -9.6% | – | – | – | – | – | – | -45.3% | |
| – | – | – | – | – | – | – | +565.5% | +176.5% | +17.4% | -14.2% | -53.2% | -60.5% | +86.2% | +38.9% | -12.2% | +149.3% | +505.6% | -33.8% | -13.2% | -14.8% | +17.7% | +155.3% | +88.8% | -11.5% | -2.5% | -31.9% | -31.7% | +151.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -29.4% | +1.3% | +6.0% | +6.6% | +16,357.7% | +90.8% | +25.9% | +12.2% | +9.3% | +15.3% | +42.4% | +11.6% | +55.0% | +115.7% | +95.5% | +22.2% | +6.4% | +21.0% | +13.2% | +17.9% | +2.1% | +3.0% | +1.6% | +1.3% | +12.2% | +11.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.